The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein (Q43872752)

27 November 2017

title

The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein (English)

1 reference

27 November 2017

1 reference

J Wu

1

1 reference

27 November 2017

H Lin

2

1 reference

27 November 2017

D Liu

3

1 reference

27 November 2017

J Liu

4

1 reference

27 November 2017

N Wang

5

1 reference

27 November 2017

X Mei

6

1 reference

27 November 2017

J Sun

7

1 reference

27 November 2017

G Yang

8

1 reference

27 November 2017

X Zhang

9

1 reference

27 November 2017

publication date

27 November 2012

1 reference

Journal of Endocrinological Investigation

27 November 2017

published in

1 reference

27 November 2017

volume

36

1 reference

27 November 2017

issue

7

1 reference

27 November 2017

page(s)

453-459

1 reference

Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.

27 November 2017

cites work

1 reference

12 December 2020

Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein

1 reference

12 December 2020

AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats

1 reference

12 December 2020

High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

1 reference

12 December 2020

Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein

1 reference

12 December 2020

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

1 reference

12 December 2020

Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets

1 reference

12 December 2020

Expression, localization, and function of the thioredoxin system in diabetic nephropathy

1 reference

12 December 2020

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.

1 reference

12 December 2020

Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients

1 reference

12 December 2020

High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway

1 reference

12 December 2020

Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.

1 reference

12 December 2020

Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity

1 reference

12 December 2020

Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage

1 reference

12 December 2020

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

12 December 2020

Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels

1 reference

12 December 2020

Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells

1 reference

12 December 2020

Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes

1 reference

12 December 2020

Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling

1 reference

12 December 2020

Transcriptional regulation of cytokines and oxidative stress by gallic acid in human THP-1 monocytes

1 reference

12 December 2020

Oxidative stress as a major culprit in kidney disease in diabetes

1 reference

12 December 2020

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

12 December 2020

Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.

1 reference

12 December 2020

Angiotensin inhibition stimulates PPARgamma and the release of visfatin

1 reference

12 December 2020

Angiotensin II enhances hyperpolarization-activated currents in rat aortic baroreceptor neurons: involvement of superoxide

1 reference

12 December 2020

PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose

1 reference

12 December 2020

Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy

1 reference

12 December 2020

Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-ac

1 reference

12 December 2020

Effects of salvianolic scid A on plantar microcirculation and peripheral nerve function in diabetic rats

1 reference

12 December 2020

Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist

1 reference

12 December 2020

Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells

1 reference

12 December 2020

The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange

1 reference

12 December 2020

Identifiers

DOI

10.3275/8764

1 reference

Dimensions Publication ID

27 November 2017

1078656965

0 references

1 reference